Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle Fahrbach

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cancer Research and Clinical Oncology|August 23, 2018
Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysisHoward L Kaufman, Lawrence H Schwartz, William N William, et al.
Dermatology and Therapy|October 7, 2020
Correction to: Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Oncology and Therapy|March 7, 2026
A Meta-analysis Investigating Response Rates with Continuous Bruton Tyrosine Kinase Inhibitor Monotherapies in the Treatment of B Cell LymphomasPier Luigi Zinzani, Rhys Williams, Mei Xue, et al.
Future Oncology (London, England)|November 20, 2018
A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemiaAjibade O Ashaye, Zarmina Khankhel, Yingxin Xu, et al.
Advances in Therapy|June 6, 2023
SABAs as Reliever Medications in Asthma Management: Evidence-Based ScienceIsrael Amirav, Gabriel Garcia, Bao Khac Le, et al.
Dermatology and Therapy|October 10, 2021
Response to the Letter to the Editor Regarding "Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systemic Literature Review and Network Meta-Analysis"Kyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Ophthalmology|August 7, 2007
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysisTien Y Wong, Tien Wong, Usha Chakravarthy, et al.
Dermatology and Therapy|May 22, 2020
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Journal of the American College of Surgeons|January 27, 2007
Minimally invasive colorectal resection outcomes: short-term comparison with open proceduresJ Kay Noel, Kyle Fahrbach, Rhonda Estok, et al.
Leukemia & Lymphoma|November 9, 2018
A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysisKatja Weisel, Pieter Sonneveld, Andrew Spencer, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|August 23, 2018
Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysisHoward L Kaufman, Lawrence H Schwartz, William N William, et al.
Dermatology and Therapy|October 7, 2020
Correction to: Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Oncology and Therapy|March 7, 2026
A Meta-analysis Investigating Response Rates with Continuous Bruton Tyrosine Kinase Inhibitor Monotherapies in the Treatment of B Cell LymphomasPier Luigi Zinzani, Rhys Williams, Mei Xue, et al.
Future Oncology (London, England)|November 20, 2018
A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemiaAjibade O Ashaye, Zarmina Khankhel, Yingxin Xu, et al.
Advances in Therapy|June 6, 2023
SABAs as Reliever Medications in Asthma Management: Evidence-Based ScienceIsrael Amirav, Gabriel Garcia, Bao Khac Le, et al.
Dermatology and Therapy|October 10, 2021
Response to the Letter to the Editor Regarding "Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systemic Literature Review and Network Meta-Analysis"Kyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Ophthalmology|August 7, 2007
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysisTien Y Wong, Tien Wong, Usha Chakravarthy, et al.
Dermatology and Therapy|May 22, 2020
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Journal of the American College of Surgeons|January 27, 2007
Minimally invasive colorectal resection outcomes: short-term comparison with open proceduresJ Kay Noel, Kyle Fahrbach, Rhonda Estok, et al.
Leukemia & Lymphoma|November 9, 2018
A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysisKatja Weisel, Pieter Sonneveld, Andrew Spencer, et al.
Pageof 6